22 May 2013
Keywords: gsk, forms, amyloidosis, partnership, univ, uk, drug
Article | 30 March 2009
UK drug major GlaxoSmithKline has formed a collaboration to develop a drug-antibody dual treatment for amyloidosis with the University College
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
30 March 2009
21 May 2013
© 2013 thepharmaletter.com